Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury - Wikidata - awgldk - TriplyDB

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

http://www.wikidata.org/entity/Q24657261

about

Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing Metabolomics and cardiovascular biomarker discovery Modeling and Classification of Kinetic Patterns of Dynamic Metabolic Biomarkers in Physical Activity Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study.Proteomic analysis of effluents from perfused human heart for transplantation: identification of potential biomarkers for ischemic heart damage Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemia.Characterization of 1H NMR spectroscopic data and the generation of synthetic validation sets.Direct control of mitochondrial function by mTOR.A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.Metaorganismal nutrient metabolism as a basis of cardiovascular disease A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells Cardiovascular networks: systems-based approaches to cardiovascular disease Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach Increases in myocardial workload induced by rapid atrial pacing trigger alterations in global metabolism.Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits Metabolite profiling identifies markers of uremia.Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes.Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets.Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.Analytical approaches to metabolomics and applications to systems biology Metabolic signatures of exercise in human plasma Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.Metabolic profiling for detection of Staphylococcus aureus infection and antibiotic resistance.The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series)A role for cytosolic isocitrate dehydrogenase as a negative regulator of glucose signaling for insulin secretion in pancreatic ß-cells.Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.Biomarkers: hopes and challenges in the path from discovery to clinical practice.Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.

P2860

Q24646027-6E186AF7-81ED-43FE-8E0E-6DD5F914CBA6 Q26991473-40EBF9C1-0AEB-41AE-B9E8-67D5B3E5AB77 Q28387059-1F91F0BB-9B73-4B39-AA19-BE6525C06C82 Q28395328-5D41FFCE-F611-4026-AF82-2DA824EDEA47 Q28396881-0FC4EBFA-27E2-47D5-993C-FB1BBD8EB146 Q28481679-4E99DEC8-A50B-43C6-A1EA-04765D31A3BE Q28545045-1D2BC1CD-CDDE-475F-8958-7AAC68A3A09A Q28588941-62B46838-BCB7-4531-AA71-118F2533091B Q28656449-7487CBB4-214E-420E-B621-F5B96F7D77F1 Q30426457-337D7187-9F80-4E72-97E3-B0FB2188DCA3 Q30426945-5138F182-C595-4F6E-9FEA-6BE20408238B Q30487537-C4314E62-3EB3-45DE-A235-7084BBB34A2E Q30665892-6E31B93F-07DF-47EF-AF2B-07ED5F0DEFBF Q33503984-2B152015-018B-499F-AEAE-2591B316856B Q33552261-391DE800-8208-4368-B02B-E5F5BF2EF313 Q33581735-24208AA3-EB0F-4BEE-A56C-5792B2FAFD89 Q33600550-50AFB129-583B-4E24-B0C9-D06D254BEFC2 Q33667520-85E5A7B0-446A-4B26-B624-D48DBD4CD57E Q33717801-7B8B097B-CD64-4C59-9F00-812F52DE8AA9 Q33728538-2B00429E-947D-4FB4-B9BA-85CAD10F59B0 Q33763313-58E35709-2F1E-42A0-B47D-D0BA3A94A6E4 Q33892283-57158687-9B69-4D26-B7AC-FF6DC96D3751 Q33970039-7F12F161-2250-45EA-81C0-94A60AF372EA Q33979275-F246BB2A-3055-48B5-AAC6-6992DCBD865D Q34032238-94DFBFA1-5E82-49E1-816A-8046C7AAA481 Q34128364-1C67B7A7-B2E3-41E7-98D4-0C82F5C2A98B Q34164910-EE6F74FA-1C5C-45A5-A33B-615AA32DB0DA Q34165559-62009B1D-417F-4894-AF49-5D6AC26147C7 Q34340503-6D791CE3-0BF9-477D-9650-3048DD88209C Q34441396-91B48066-D0C6-4EBB-979C-A51D895882BF Q34497155-8CB22075-C09B-4926-9EA4-166D6B368B5D Q34602823-C0A176F9-540E-4D45-9394-E03878DE1A25 Q34782469-303A3691-52FE-4F09-8591-C9E17560EC04 Q35018731-1E2B2160-C71B-41A5-9E3B-D7A5E88CBA90 Q35098539-C0AFB2D3-9BA9-4BF3-885E-1936959F99B1 Q35156688-32583B6A-2CCA-47BA-A4FC-9D246B7AF7E0 Q35187726-0F5A0D1A-4C59-4643-B5E8-A1123BC2C2D7 Q35219088-3A19513E-D148-4479-8452-FD708B0ECDAA Q35471494-4CB8F8D2-BE0A-4709-A4C8-F2901C270C7E Q35534297-CBD6CBB8-F0F1-43B1-9CE2-DBAD63CB51B3

P2860

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury

http://www.wikidata.org/entity/Q24657261

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Metabolite profiling of blood ...... y markers of myocardial injury

@ast

Metabolite profiling of blood ...... y markers of myocardial injury

@en

Metabolite profiling of blood ...... y markers of myocardial injury

@nl

type

label

Metabolite profiling of blood ...... y markers of myocardial injury

@ast

Metabolite profiling of blood ...... y markers of myocardial injury

@en

Metabolite profiling of blood ...... y markers of myocardial injury

@nl

prefLabel

Metabolite profiling of blood ...... y markers of myocardial injury

@ast

Metabolite profiling of blood ...... y markers of myocardial injury

@en

Metabolite profiling of blood ...... y markers of myocardial injury

@nl

P1433

Q24657261-F36BCC19-CC25-4964-A828-4C81A5329387

P1476

Q24657261-F7468ACE-F22C-45AA-9163-D484CFADD042

P2093

Q24657261-2845F872-C8B6-4232-8836-C5B815B1B264

Q24657261-30C4B81A-A519-4E1C-A8AF-C8DE4ABAF8AD

Q24657261-46777703-3B25-423A-A292-C4DD3D38F58A

Q24657261-4D5196A0-C911-40F7-A194-8B514F37BA25

Q24657261-58A18E1C-571D-423E-965B-CAE32ADA7572

Q24657261-5DC99288-7B4F-4D0E-BA21-041F3B8B5DD6

Q24657261-60E349B8-0658-45EF-BD1C-31A939039033

Q24657261-65A46BFF-3E6B-48D2-9A78-335D8AB5433D

Q24657261-66D00E7E-7BFE-49CD-8FE0-93414C6E0D11

Q24657261-6A548DEA-3599-4E19-80BB-2E410385B518

P2860

Q24657261-15EAB6D7-587B-49B4-AF69-B686A866E87D

Q24657261-19F62926-1468-4A0D-8294-80BBE5E1F3EA

Q24657261-2625649C-4215-48A6-BBDC-AA14DE2FA4D7

Q24657261-2E852D4B-730E-469D-945F-CD552CCF5005

Q24657261-3459E23E-80C1-41F5-BBD6-E51122BDE1C9

Q24657261-37B213D6-E4FF-41DB-BCCE-C77AC6D37F65

Q24657261-3F9BAE03-1C32-4FCC-BE6F-379512BF166F

Q24657261-412A5D99-68CA-45AC-9A91-436FFE6A8369

Q24657261-42705ACF-56AD-4F73-BDD8-C75DF2276B70

Q24657261-47E781F7-0E3D-4FDA-8A08-9B678E2C4E85

P304

Q24657261-85BE5BB3-924D-4408-8F26-3102DE6ADDC0

P31

Q24657261-AF1C3D96-2375-43CB-AA7E-38084A79A6B4

P3181

Q24657261-CE96AA84-A632-474F-BC09-B3C50408A610

P356

Q24657261-759D27CC-BCA2-46CE-8113-878CCAECB9AB

P407

Q24657261-16CA30C5-6AB6-42DA-95E8-D6462D2379CD

P433

Q24657261-FF0C8627-4B41-45DE-BB5F-9235C430447A

P478

Q24657261-F36457AE-4E31-436A-BCCC-BF95411E2296

P50

Q24657261-1E400A2F-6734-45E6-B034-677FAEE551B2

Q24657261-264628A6-6F57-4A44-BF46-AFF78FFB44D8

P577

Q24657261-A66E328E-086B-4279-BE82-C9225A3207E4

P698

Q24657261-3C9F47AE-30E4-4BB9-91CA-47284EC7CBEF

P921

Q24657261-1B944F1A-29C4-42BB-8F2A-CF7CAB65C2E5

P932

Q24657261-B6D490D5-9DA6-4EF7-8F44-E910E5099E6F

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Metabolite profiling of blood ...... y markers of myocardial injury

@en

P2093

Aarti Asnani

http://www.w3.org/2001/XMLSchema#string

Anthony Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Arvind Ramanathan

http://www.w3.org/2001/XMLSchema#string

Elaine Yang

http://www.w3.org/2001/XMLSchema#string

Emerson Liu

http://www.w3.org/2001/XMLSchema#string

Gabriel Berriz

http://www.w3.org/2001/XMLSchema#string

Gregory D Lewis

http://www.w3.org/2001/XMLSchema#string

Hasmik Keshishian

http://www.w3.org/2001/XMLSchema#string

Igor F Palacios

http://www.w3.org/2001/XMLSchema#string

Jiangyong Min

http://www.w3.org/2001/XMLSchema#string

P2860

HMDB: the Human Metabolome Database

LC/MS applications in drug development

A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations

Immune activation and degradation of tryptophan in coronary heart disease

Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy

Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors

Measurement of N tau-methylhistamine concentrations in plasma and urine as a parameter for histamine release during anaphylactoid reactions

Physiological concentrations of purines and pyrimidines

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction.

P304

3503-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1484783

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI35111

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Frederick P. Roth

Christian Baumgartner

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18769631

http://www.w3.org/2001/XMLSchema#string

P921

P932

2525696

http://www.w3.org/2001/XMLSchema#string